Skip to main content
ECHOIQ LIMITED logo

ECHOIQ LIMITED — Investor Relations & Filings

Ticker · EIQ ISIN · AU0000195430 LEI · 984500C02FCE7ADF6A81 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 520 across all filing types
Latest filing 2022-12-01 Capital/Financing Update
Country AU Australia
Listing ASX EIQ

About ECHOIQ LIMITED

https://echoiq.ai/

EchoIQ Limited is a medical technology company specializing in the development of artificial intelligence and machine learning solutions for the healthcare sector. The company focuses on enhancing the diagnosis and risk assessment of structural heart disease through its flagship platform, EchoSolv. This cloud-based clinical decision support tool utilizes proprietary algorithms to analyze echocardiographic measurement data, identifying patients at risk of conditions such as aortic stenosis and heart failure. By comparing individual patient data against established clinical guidelines and extensive cardiovascular datasets, the technology assists clinicians in detecting under-diagnosed or misdiagnosed cardiac conditions. The platform is designed to integrate into existing clinical workflows, aiming to improve diagnostic accuracy, optimize patient management, and support timely intervention in cardiovascular care.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - EIQ 8 pages 29.5KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by ECHOIQ LIMITED. It includes information about the number and type of securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. There is no financial performance data, management discussion, or audit information. The document is an official announcement related to the listing or quotation of securities on the ASX, which corresponds to a capital or financing update rather than a full financial report or regulatory filing. The document length is about 5897 characters, which is sufficient to contain substantive details about the securities quotation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-12-01 English
Application for quotation of securities - EIQ 8 pages 29.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities on the ASX (Australian Securities Exchange). It includes information about the entity, the securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. There is no financial performance data, earnings information, or management discussion. The document is an announcement related to capital markets activity, specifically the quotation of securities previously issued. This fits the category of Share Issue/Capital Change (SHA), as it relates to the issuance and quotation of new shares and securities on the exchange.
2022-12-01 English
Cleansing Notice 1 page 80.0KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice regarding the issuance of shares by Echo IQ Limited, specifically a 'S708A Cleansing Notice' related to shares issued under existing placement capacity. It references compliance with the Corporations Act 2001 and ASX Listing Rules. The content focuses on share issuance and regulatory compliance for that issuance, not on financial results, management changes, or other report types. This fits the category of announcements related to capital changes or share issues. Therefore, the document is best classified as a Share Issue/Capital Change announcement (SHA). The document length is short and it is not a report or a report publication announcement, so SHA is appropriate with high confidence.
2022-12-01 English
Echo IQ Announces Positive Results From US Clinical Study 2 pages 71.2KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing positive results from a US clinical study conducted by Echo IQ. It highlights study findings, clinical implications, and commercial prospects but does not contain financial statements, regulatory filings, or detailed financial data. It is not an annual or interim report, audit report, earnings release, or any regulatory filing. The content is focused on clinical study results and company announcements rather than financial or governance information. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general announcement that does not fit other specific categories.
2022-11-30 English
Change of Registered Address 1 page 72.6KB
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a change of the company's registered office address. It references compliance with Listing Rule 3.14 but does not contain any financial data, management discussion, or detailed report content. The document length is only 1033 characters, indicating it is a brief notice rather than a full report. It is not a financial report, earnings release, or management information. It is also not a regulatory certification or insider dealing report. The content fits best as a general regulatory announcement about a corporate administrative change. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-11-30 English
Ceasing to be a substantial holder 3 pages 397.4KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and shareholdings of JPMorgan Chase & Co. and its affiliates, including transactions and associations. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2022-11-29 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.